Nessel Email Header




*FOR IMMEDIATE RELEASE:*

June 13, 2024




*Media Contact:
*Danny Wimmer <[email protected]>






AG Nessel Issues Statement on Supreme Court Upholding Access to Abortion Pill Mifepristone??





*LANSING* ??Today, the U.S. Supreme Court issued an opinion rejecting an attempt to limit women's right to reproductive freedom.??In "Food and Drug Administration, et al. v." "Alliance for Hippocratic Medicine, et al., "the U.S. Supreme Court issued a unanimous decision that the Plaintiffs ? a group of anti-choice medical associations and individual doctors ? do not have standing to challenge the United States Food and Drug Administration?s regulation of mifepristone. ? ?

"For over two decades, millions of women in Michigan and across our country have trusted mifepristone, a safe, effective medication used in the majority of abortions,? Nessel said. ?Today?s ruling is a victory for every woman?s right to choose. I'm glad to see this absurd attempt by a handful of people to block access to safe health care options defeated. While we celebrate this win for bodily autonomy, this is just one battle in the never-ending fight to protect?the right to an abortion. As we speak, legislatures across the nation are drafting new bans to care and lower courts are considering novel challenges to everything from birth control to IVF.? My commitment to protecting reproductive freedom for women throughout our great state remains unwavering.? ?

Mifepristone is one drug of the two-drug regimen used for medication abortion.? Medication abortion is a safe alternative to procedural abortion, and more than half of abortions in the United States are performed using medication.??

The?U.S.?Supreme Court reasoned that because the plaintiffs do not prescribe, manufacture, sell, or advertise mifepristone or a competing drug, plaintiffs do not have standing to challenge the Food and Drug Administration?s regulations related to the same. This ruling means that pregnant women in Michigan and throughout the United States will continue to have access to mifepristone pursuant to current regulations on prescription, dispensing, and use. ?Moreover, this ruling should discourage future challenges by anti-abortion organizations not directly affected by abortion regulations. ?

"###"






AG logo [ [link removed] ]





*Media Inquiries* <[email protected]>




*Latest Releases* [ [link removed] ]




*File a Complaint* [ [link removed] ]







________________________________________________________________________

Michigan Department of the Attorney General [ [link removed] ] ? Questions?
? Contact Us [ [link removed] ]

STAY CONNECTED: Visit us on Twitter [ [link removed] ] Instagram logo [ [link removed] ] Visit us on Facebook [ [link removed] ] YouTube [ [link removed] ] Sign up for email updates [ [link removed] ] ? ? ?

Bookmark and Share [ [link removed] ]

SUBSCRIBER SERVICES:
Manage Preferences [ [link removed] ]??|?Help [ [link removed] ]

________________________________________________________________________

This email was sent to [email protected] using GovDelivery Communications Cloud on behalf of: Michigan Attorney General ? G. Mennen Williams Building, 7th Floor?? 525 W. Ottawa St., P.O. Box 30212 ? Lansing, MI 48909?? 517-373-1100